Aflatoxin, Its Metabolism and Carcinogenesis - A Historical Review

References

• Autrup H. Exposure to Aflatoxins in Denmark. J. Toxicol.-Toxin Reviews 1989; 8: 53
   Web of Science ®Google Scholar
• Groopam J. D., Cain L. G., Kenster T. W. Aflatoxin Exposure in Human Populations: Measurements and Relationship to Cancer, CRRC Crit. Rev. Toxicol. 1988; 19: 113
   Google Scholar
• Peers F. G., Linsell C. A. Dietary Aflatoxins and Liver Cancer- A population based Study in Kenya. Br. J. Cancer 1973; 24: 473
   Google Scholar
• Peers F. G., Linsell C. A. Dietary Aflatoxins and Human Primary Liver Cancer. Ann. Nutr. Aliment. 1977; 31: 1005
   PubMedGoogle Scholar
• Peers F. G., Gilman G. A., Linsell C. A. Dietary Aflatoxins and Human Liver Cancer: A study in Swaziland. Int. J. Cancer 1976; 17: 167
   PubMed Web of Science ®Google Scholar
• van Resisburg S. J. Mycotoxins in Human and Animal Health, J. V. Rodricks, C. W. Hesseltine, M. A. Mehlman. Pathotox Publications, USA 1977
   Google Scholar
• Chainuvati T., Viranuvatt V., Pongipat D. Relationship of Hepatitis B Antigen in Cirrhosis and Hepatoma in Thailand: An Epidemiological Significance. Gastroenterology 1975; 68: 1261
   PubMed Web of Science ®Google Scholar
• Prince A. M., Szmuness W., Michon J., Demaille J., Diebolt G., Linharrd J., Quenum C., Sankale M. A Case Control Study of the Association between Primary Liver Cancer and hepatitis B Infection in Senegal. Int. J. Cancer 1975; 16: 376
   PubMed Web of Science ®Google Scholar
• Reys L. L., Sequeira O. A. Detection of Australia Antigen (HBAg) in Blood Donors and Hepatoma Patients in Mozambique. S. Afr. Med J. 1974; 48: 267
   PubMed Web of Science ®Google Scholar
• Vogel C. L., Anthony P. P., Mody N., Barker L. F. Hepatitis Associated Antigen in Uganda Patients with Hepatocellular Carcinoma. Lancet 1970; 2: 621
   PubMed Web of Science ®Google Scholar
• Uchida T., Suzuki K., Esami M., Arii M., Shikara T. Influence of Intoxication on Duct Livers and Duck Hepatitis b Virus infection. Cancer Res. 1988; 48: 1559
   PubMed Web of Science ®Google Scholar
• Peers F., Bosch X., Kolder J., Linsell A., Pluijmen M. Aflatoxin Exposure, Hepatitis B Virus Infection and Liver Cancer in Swaziland. Int. J. Cancer 1987; 39: 545
   PubMed Web of Science ®Google Scholar
• Stoloff L. Aflatoxin is not a probably human carcinogen: The published Evidence is sufficient. Regul. Toxicol. Pharmacol. 1989; 10: 272
   PubMed Web of Science ®Google Scholar
• Cova L., Wild C. P., Mehrotra R., Turusov V., Shirai T., Lambert V., Jacquet C., Tomatis L., Trepo C., Montesano R. Contribution of Aflatoxin B1 and Hepatitis B Virus infection in the Induction of Liver Tumors in Ducks. Cancer Res. 1990; 50: 2156
   PubMed Web of Science ®Google Scholar
• Kaldor J. M., Bosch F. X. Multistage Theory of Carcinogenesis: The Epidemiological Evidence of Liver Cancer. Bull. Cancer (Paris) 1991; 77: 457
   Web of Science ®Google Scholar
• Villa E., Melegari M., Scaglioni P. P., Trande P., Mamenti F. Hepatocellular Carcinoma: Risk Factors other than HBV. Ital. J. Gastroenterol. 1991; 23: 457
   PubMedGoogle Scholar
• Stoloff L. Aflatoxin is not a probably human carcinogen: the published evidence is sufficient. Regulatory Toxicol. Pharmacol. 1989; 10: 272
   PubMed Web of Science ®Google Scholar
• Marshall E. A Breath Test for Cancer. Science 1993; 259: 1395
   PubMed Web of Science ®Google Scholar
• Suit J. L., Rogers A. E., Jetten M., Luria S. E. Effect of Diet on conversion of Aflatoxin B1 to Bacterial Mutagenesis by Rats in vivo and by Rat Hepatic Microsomes in vitro. Mutat. Res. 1977; 46: 313
   Google Scholar
• Rizvi T. A., Mathur M., Nayak N. C. Effects of Protein Calorie Malnutrition and Cell Replication of Aflatoxin B1 Induced Hepatocarcinogenesis. J. Nat. Cancer Inst. 1987; 70: 817
   Google Scholar
• Dunaif E., Campbell T. Relative Contribution of Dietary Protein Level and Aflatoxin B1 Dose in Generation of Presumptive Preneoplastic Foci in Rat Liver. J. Natl. Cancer Inst. 1987; 78: 365
   PubMed Web of Science ®Google Scholar
• Appleton B. S., Campbell T. Effect of High and Low Dietary Protein on the Dosing Periods of AFB1-Induced Hepatic Preneoplastic Lesion Development in the Rat. Cancer Res. 1983; 43: 2150
   PubMed Web of Science ®Google Scholar
• Hafez A. H., Gomma A., Mousa S. A., Megalla S. E. Aflatoxin and Aflatoxicosis. IV. The effect of Dietary Aflatoxin on Adult Male and Female rabbits at Various Reproductive Conditions. Mycopathologia 1983; 83: 183
   Web of Science ®Google Scholar
• Ostrowski M., Henry T. Biochemical and Physiological Responses of Growing Chickens and Ducklings to Dietary Aflatoxin. Comp. Biochem. Physiol. & Comp. Pharmacol. Toxicol. 1984; 79: 193
   PubMed Web of Science ®Google Scholar
• Marion E., Cindy D., Gross W. Effect of Dietary Exposure of Aflatoxin B1 on Resistance of Young Chickens to Organophosphate Pesticide Challenge. Avian Dis. 1985; 29: 715
   PubMed Web of Science ®Google Scholar
• Potchinsky M. B., Bloom S. E. Selective Aflatoxin B1-induced Sister Chromatid Exchanges and Cytotoxicity in Differentiating B & T-Lymphocytes in vivo. Environ. Mol. Mutagen. 1993; 21: 87
   PubMed Web of Science ®Google Scholar
• Lotliker P. D. Metabolic Basis for Susceptibility and Resistance to Aflatoxin B1-Hepatocarcinogenesis in Rodents. J. Toxicol.-Toxin Reviews 1989; 8: 97
   Web of Science ®Google Scholar
• Campbell T. C., Hayes J. R. The Role of Aflatoxin Metabolism in its Toxic Lesion. Toxicol. Appl. Pharmacol. 1976; 35: 199
   PubMed Web of Science ®Google Scholar
• Miller J. A., Miller E. C. Ultimate Chemical Carcinogenesis as Reactive Mutagenic Electrophiles, In: Origins of Human Cancer, H. H. Hiatt, J. D. Watson, J. A. Winsten. Cold Spring Harbor. 1977; 605
   Google Scholar
• Essigmann J. M., Croy R. G., Nadzan A.W. F., Jr, Reinhold V. N., Buchi G., Wogan G. N. Structural Identification of the Major DNA Formed by Aflatoxin B1 in vitro. Proc. Natl. Acad. Sci., USA. 1977; 74: 1870
   PubMed Web of Science ®Google Scholar
• Essigman J. M., Croy R. G., Bennett R. A., Wogan G. N. Metabolic Activation of Aflatoxin B1: Patterns of DNA Adduct Formation, Removal and Excretion in Relation to Carcinogenesis. Drug Metab. Rev. 1982; 13: 581
   PubMed Web of Science ®Google Scholar
• Wong J. J., Hsieh D. P.H. Mutagenicity and Aflatoxins Related to their Metabolism and Carcinogenesis Potential. Proc. Natl. Acad. Sci., USA. 1976; 73: 2241
   PubMed Web of Science ®Google Scholar
• Gurtoo H. L., Dahms R. P., Paigen B. Metabolic Activation of Aflatoxins Related to their Mutagenicity. Biochem. Biophys. Res. Commun. 1978; 81: 965
   PubMed Web of Science ®Google Scholar
• Croy R. G., Wogan G. N. Temporal Patterns of Covalent DNA Adducts in Rat Liver after Single and Multiple Doses of AFB1. Cancer Res. 1981; 41: 1197
   Web of Science ®Google Scholar
• Leadon S. A., Tyrrell R. M., Wutti P. A. Excision Repair of Aflatoxin B1 DNA Adducts in Fibroblasts. Cancer Res. 1981; 41: 5125
   PubMed Web of Science ®Google Scholar
• Irvin R., Wogan G. N. Quantitative and Qualitative Characterization of AFB1 Adducts Formed with in the Ribosomal RNA Genes of Rat Liver DNA. Cancer Res. 1985; 45: 3497
   PubMed Web of Science ®Google Scholar
• Gordon R., Eric J. P. Effects of Variations in Nucleoside Pool Sizes on Comparisons of the Incorporation of [3H] Thymidine into Isolated Rat Liver Cells. Cancer Res. 1980; 40: 3719
   PubMed Web of Science ®Google Scholar
• Newberne P. M., Butler W. H. Acute and Chronic Effects of Aflatoxin on the Liver of Domestic and Laboratory Animals: A review. Cancer Res. 1969; 29: 236
   PubMed Web of Science ®Google Scholar
• Herrold K. M. Aflatoxin Induced Lesions in Syrian hamsters. Br. J. Cancer 1969; 23: 655
   PubMed Web of Science ®Google Scholar
• Moore M. R., Pitot H. C., Miller E. C., Miller J. A. Cholangiocellular Carcinomas Induced in Syrian Golden Hamsters Administered Aflatoxin B1 in Large Doses. J. Natl. Cancer Inst. 1982; 68: 271
   PubMedGoogle Scholar
• Swenson D. H., Lin J. K., Miller E. C., Miller J. A. Aflatoxin B1-2,3-Oxide as a Probable Intermediate in the Covalent Binding of Aflatoxin B1 and B2 to Rat Liver DNA and Ribosomal RNA in vivo. Cancer Res. 1977; 37: 172
   PubMed Web of Science ®Google Scholar
• Bennett R. A., Essigmann J. M., Wogan G. N. Excretion of a AF-Guanine Adduct in the Urine of AFB1 Treated Rats. Cancer Res. 1981; 41: 650
   PubMed Web of Science ®Google Scholar
• Bhatt N. K., Emeh J. K., Niranjan B. G., Avadhani N. G. Inhibition of Mitochondrial Protein Synthesis During Early Stages of AFB1-Induced Hepatocarcinogenesis. Cancer Res. 1982; 42: 1876
   PubMed Web of Science ®Google Scholar
• Moss E. J., Judah D. J., Przyblski M., Neal G. E. Some Mass Spectral and M.M.R. Analytical Studies on a Glutathione Conjugate of Aflatoxin B1. Biochem. J. 1983; 210: 227
   PubMed Web of Science ®Google Scholar
• Power C., Sihna S., Webber C., Manson M. M., Neal G. E. Transformation Related Expression of Glutathione-S-Transferase P in Rat Liver Cells. Carcinogenesis 1987; 8: 797
   PubMed Web of Science ®Google Scholar
• Hayes J. R., Korr L. A., Harrison J. D., Cronshaw A. D., Ross A. G., Neal G. E. Preferential, Over-expression of the Class Alpha Rat Ya2 Glutathione-S-transferase Subunit in Liver bearing Aflatoxin-Induced Pre-Neoplastic Nodules. Comparison of the Primary Structure of Ya1 and Ya2 with Cloned Class Alpha Glutathione-S-Transferase cDNA Sequence. Biochem. J. 1990; 268: 295
   PubMed Web of Science ®Google Scholar
• Goeger D. E., Shelton D. W., Hendricks J. D., Pereira C., Bailey G. S. Comparative Effect of Dietary Butylated Hydroxyanisole and Beta-Napthoflavone on Aflatoxin B1 Metabolism, DNA Adduct Formation and Carcinogenesis in Rainbow Trout. Carcinogenesis 1988; 9: 1793
   PubMed Web of Science ®Google Scholar
• Bailey G. S., Williams D. E., Wilcox J. S., Loveland P. M., Coulombe R. A., Hendricks J. D. Aflatoxin B1 Carcinogenesis and its Relation to DNA Adducts Formation and Adduct Persistence in Sensitive and Resistant Salmoid Fish. Carcinogenesis 1988; 9: 1919
   PubMed Web of Science ®Google Scholar
• Wilson D. W., Ball R. W., Coulombe R. Comparative Action of Aflatoxin B1 in Mammalian Airways Epithelium. Cancer Res. 1990; 50: 2493
   PubMed Web of Science ®Google Scholar
• Bailey G. S., Hendricks J. D., Shelton D. W., Nixon J. F., Poulaski N. E. J. Natl. Cancer. Inst. 1987; 78: 931
   PubMed Web of Science ®Google Scholar
• Dashwood R. H., Arbogast D. N., Fong A. T., Pereira C., Hendricks J. D., Bailey G. S. Quantitative Inter-Relationship Between Aflatoxin B1 carcinogen Dose, Indole-3-Carbinol Anti-Carcinogen Dose, Target Organ DNA Adduction and final Tumor Response. Carcinogenesis 1989; 10: 175
   PubMed Web of Science ®Google Scholar
• Dashwood R. H., Fong A. T., Hendricks J. D., Bailey G. S. Tumor Dose-Response Studies with Aflatoxin B1 and the Ambivalent Modulator Indole-3-Carbinol: Inhibitory Versus Promotional Potency. Basic Life Sci. 1990; 52: 361
   PubMedGoogle Scholar
• Dashwood R. H., Fong A. T., Williams D. E., Hendricks J. D., Bailey G. S. Promotion of Aflatoxin B1 carcinogenesis by the Natural Tumor Modulator Indole-3-Carbinol: Influence of Dose, Duration and Intermittent Exposure on Indole-3-Carbinol Promotional Potency. Cancer Res. 1991; 51: 2362
   PubMed Web of Science ®Google Scholar
• Fong A. T., Swanson H. I., Dashwood R. H., Williams D. E., Hendricks J. D., Bailey G. S. Mechanisms of Anti-Carcinogenesis by Indole-3-Carbinol. Studies of Enzyme Induction, Electrophile-Scavenging and Inhibition of Aflatoxin B1 Activation. Biochem. Pharmacol. 1990; 39: 19
   PubMed Web of Science ®Google Scholar
• Bailey G. S., Dashwood R. H., Fong A. T., Williams D. E., Scanlan R. A., Hendricks J. D. Modulation of Mycotoxins and Nitrosamine Carcinogenesis by Indole-3-Carbinol: Quantitative Analysis of Inhibition Versus Promotion. IARC Sci. Publ. 1991; 105: 275
   Google Scholar
• Hullahalli R., Prasanna K. D., Nakamura F., Sayed A., Ming H., Slikker W., Ronald W. H. Altered Hepatic Microsomal Function and Elevated Proto-oncogene Expression as Residual Effects in Rats Exposed to Delta-9-Tetrahydrocannabinol. Biochem. Biophys. Res. Commun. 1989; 160: 217
   PubMed Web of Science ®Google Scholar
• Shimada T., Guengerich F. P. Evidence for Cytochrome P-450 NF, the Nifedipine Oxidase, Being the principal Enzyme Involved in the Bioactivation of Aflatoxin in Human Liver. Proc. Natl. Acad. Sci., USA. 1989; 86: 462
   PubMed Web of Science ®Google Scholar
• Ramsdell H. S., Eaton D. C. Species Susceptibility to Aflatoxin B1 carcinogenesis: Comparative Kinetics of Microsomal Biotransformation. Cancer Res. 1990; 50: 615
   PubMed Web of Science ®Google Scholar
• Ramsdell H. S., Parkinson A., Eddy A. C., Eaton D. L. Bioactivation of Aflatoxin B1 by Human Liver Microsomes: Role of Cytochrome P-450 A Enzymes. Toxicol. Appl. Pharmacol. 1991; 108: 436
   PubMed Web of Science ®Google Scholar
• Daniels J. M., Massey T. E. MOdulation of Aflatoxin B1 Biotransformation in Rabbit Pulmonary and Hepatic Microsomes. Toxicol. 1992; 74: 19
   PubMed Web of Science ®Google Scholar
• Hsieh D. P., Atkinson D. N. Bisfuranoid Myotoxins: Their Genotoxicity and Carcinogenicity. Adv. Exp. Med. Biol. 1991; 283: 525
   PubMedGoogle Scholar
• Columbe R. A., Hine J. M., Ball R. W., Sharma R. P., Wilson D. W. Pharmacokinetics of Intratracheally Administered Aflatoxin B1. Toxicol. Appl. Pharmacol. 1991; 109: 196
   PubMed Web of Science ®Google Scholar
• Coles B., Meyer D. J., Ketterer B., Stanton C. R., Garner R. Studies on the Detoxication of Microsomally Activated Aflatoxin B1 by Glutathione Transferase. Carcinogenesis 1693; 6: 693
   Google Scholar
• Yu F., Bender W, Wu Z. G. Transcriptional Effect of Aflatoxin B1 on Cytosine and/or Hypoxanthine Containing DNAs. Mol. Cell. Biochem. 1991; 103: 1
   PubMed Web of Science ®Google Scholar
• Green J. A., Carthew P., Heuillet F., Simpson J. L., Manson M. M. Cytokeratin Expression during AFB1-Induced Carcinogenesis. Carcinogenesis 1990; 11: 1175
   PubMed Web of Science ®Google Scholar
• Harvey R. B., Clark D. E., Haff W. E., Kubena L. F., Corrier D. E., Phillips T. D. Suppression of Serum Iron-binding Capacity and Bone Marrow Cellularity in Pigs Fed Aflatoxin. Bull. Environ. Contam. Toxicol. 1988; 40: 57
   Web of Science ®Google Scholar
• GrosmanElias M. E., Comin E. J., Rodriguez G. A.E. Distal Nephron Functions of the Rat During Acute Aflatoxicosis. Toxicol. Lett 1984; 21: 263
   PubMed Web of Science ®Google Scholar
• Williams D. E., Buhler D. R. Purified Form of Cytochrome P-450 from Rainbow Trout with High Activity towards Conversion of AFB1 and AFB-2–3 Epoxide. Cancer Res. 1983; 43: 4752
   PubMed Web of Science ®Google Scholar
• Karenlampi S. O. Mechanism of Cytotoxicity of Aflatoxin B1: Role of Cytochrome P1-450. Biochem. Biophys. Res. Commun. 1987; 145: 854
   PubMed Web of Science ®Google Scholar
• Koser L., Faletto M. B., Bansal S. K., Cabelles L., Bresnick E., Hines R. N., Gurtoo H. L. Aflatoxin B1–2-hydrolase is Associated with Cytochrome P3-450 in C57BL/6 Mouse Liver. Biochem. Biophys. Res. Commun. 1987; 142: 872
   PubMed Web of Science ®Google Scholar
• Weekly L. B., Kembrough T. D., Liewellyn G. C. Disturbances in Tryptophan Metabolism in Rats following Chronic Dietary Aflatoxin Treatment. Drug Chem. Toxicol. 1985; 8: 145
   PubMed Web of Science ®Google Scholar
• Adzhigitov F. I., Kosichenko L. P., Popandopulo P. G., Gubelaze D. A., Dzhemilev Z. A. Frequency of Chromosome Aberrations in Bone Marrow of Monkeys and their F1 after Aflatoxin B1 Injection. Exp. Pathol. 1884; 26: 163
   Google Scholar
• Uwaifo A. O., Billings P. C., Heodelberger C. Mutation of Chinese Hamster V79 Cells and Transformation and Mutation of Mouse Fibroblast C3H/10T1/2 Clone 8 Cells by AFB1. Cancer Res. 1983; 43: 1054
   PubMed Web of Science ®Google Scholar
• Fahmy M. J., Fahmy O. G. Differential Induction of Altered Gene Expression by Carcinogens of Mutant Alleles of a Drosophila Locus with a Transposable Element. Cancer Res. 1983; 43: 801
   PubMed Web of Science ®Google Scholar
• Kalensky H., Mor L., Stark A. V. Comparative AFB1 Mutagenesis of Salmonella Typhimurium T-100 in Metabolic and Photo-activation System. Cancer Res. 1984; 44: 1831
   PubMed Web of Science ®Google Scholar
• Wood M., Smith J. R., Garner R. C. Aflatoxin B1 Activation to a Plasmid Mutagen by a Chemical Model of Cyrochrome P-450. Mutat. Res. 1987; 176: 11
   PubMedGoogle Scholar
• San R. H.C., Chan R. I.M. Inhibitory Effect of Phenolic Compounds on Aflatoxin B1 Metabolism Induced Mutagenesis. Mutat. Res. 1987; 177: 229
   PubMed Web of Science ®Google Scholar
• Kaden A., Call M., Leons P. M., Korhives E. A., Thilly W. G. Killing and Mutation of Human Lymphoblast Cells by Aflatoxin B1: Evidence for an Inducible Repair Response. Cancer Res. 1987; 47: 993
   Web of Science ®Google Scholar
• Refolo L. M., Bennett C. B., Humayun M. Z. Mechanism of Frame shift Mutagenesis by AFB1 2,3-Dichloride. J. Mol. Biol. 1987; 193: 609
   PubMed Web of Science ®Google Scholar
• Steinmetz K. L., Green C. E., Bakke J. P., Spak D. K., Mirsalis J. C. Induction of Unscheduled DNA Synthesis in Primary Cultures of Rat, Mouse, Hamster, Monkey and Human Hepatocytes. Mutat. Res. 1988; 206: 91
   PubMed Web of Science ®Google Scholar
• Aoyoma T., Yamona S., Guzelian P. S., Gelboin H. V., Gonzalez F. J. Five of Twelve forms of Vaccinia Virus Expressed Human Hepatic Cytochrome P-450 Metabolically Activate Aflatoxin B1, Proc. Natl. Acad. Sci. USA. 1990; 87: 4790
   PubMed Web of Science ®Google Scholar
• Crepsi L. C., Penman B. W., Steimel D. T., Gelboin H. V., Gonzalez F. J. The Development of a human Cell line Stably Expressing Human CYP3A4: Role in the Metabolic Activation of Aflatoxin B1 and Comparison to CYP1A2 and CYP2A3. Carcinogenesis 1991; 12: 355
   PubMed Web of Science ®Google Scholar
• Bressac B., Kew M., Wands J., Ozturk M. Selective G to T Mutation of p53 Gene in Hepatocellular Carcinoma from South Africa. Nature 1991; 350: 429
   PubMed Web of Science ®Google Scholar
• Kruster L., Raichev R., Kamenova B., Beshevlieva M. Ultrastructural characteristics of Fibromyosarcoma Developed in Experimental Chronic Aflatoxin Intoxication and Inadequate Nutrition. Onkologia 1985; 22: 86
   Google Scholar
• Elmofty M. M., Sakr S. A. The Induction of Neoplastic Lesions by AFB1 in the Egyptian Toad (Bufo regularis). Egy. Nutr. Cancer 1988; 11: 55
   PubMed Web of Science ®Google Scholar
• Iverson, Campbell J., Clayson D., Heirliby S., Labossiere E., Hayward S. Effects of Antioxidants on Aflatoxin Induced Hepatic Tumors in Rats. Cancer Lett. 1987; 34: 139
   PubMed Web of Science ®Google Scholar
• Schoenhard G. L., Hendricks J. D., Noxon J. E., Lee J. D., Wales J. H., Scunhuder R. O., Pawlowsky N. E. Aflatoxicol Induced Hepatocellular Carcinoma in Rainbow Trout (salmogairdneri) and the Synergestic Effects of Cyclo-propenoid Fally. Cancer Res. 1981; 41: 1011
   PubMed Web of Science ®Google Scholar
• Muller N., Pelzinger E. Hepatocellular Uptake of AFB1 Non-ionic Diffusions: Inhibition of Bile Acid Transport by Interference with Membrane Lipids. Biochim. Acta. Ser. Biomembr. 1988; 938: 334
   PubMed Web of Science ®Google Scholar
• Stora C., Drorackova I., Ayraud N. Characterization of AFB1 in Human Liver Cancer. Res. Commun. Chem. pathol. Pharmacol. 1981; 31: 77
   PubMedGoogle Scholar
• Neal G. E., Judah D., Green J. A. The in vitro Metabolism of AFB1 Catalyzed by Hepatic Microsome Isolated from Control or 3-Methylcholanthrene-stimulated Rats and Quail. Toxicol. Appl. Pharmacol. 1986; 82: 450
   Web of Science ®Google Scholar
• Zhang Y. J., Chen C. J., Lee C. S., Haghighi B., Yang G. Y., Wang L. W., Feitelson M., Santella R. Aflatoxin B1 -DNA Adducts and Hepatitis B virus Antigens in Hepatocellular carcinoma and Non-Tumorous Liver tissue. Carcinogenesis 1991; 12: 2247
   PubMed Web of Science ®Google Scholar
• Blackburn G. R., Andrews J. A., Custer R. P., Sorof S. Early events During liver carcinogenesis Involving Two Carcinogen: Protein Complexes. Cancer Res. 1981; 41: 4039
   PubMed Web of Science ®Google Scholar
• Dirr W. Effects of Hydrogen Ion and fatty Acid Concentrations on the Binding of Aflatoxin B1 to Human Albumin. Biochem. Int. 1987; 14: 727
   PubMedGoogle Scholar
• Modali R., Yang S. S. Specificity of Aflatoxin B1 Binding on Human Proto-Oncogene Nucleotide Sequence. Prog. Clin. Biol. Res. 1986; 207: 147
   PubMedGoogle Scholar
• Tashiro F., Morimura S., Hayashi K., Makino R., Kawamura H., Horikoshi N., Nemoto K., Ohtsubo K., Sugimura T., Ueno Y. Expression of the c-Ha-ras and Cmyc Genes in Aflatoxin B1-Induced Hepatocellular Carcinomas. Biochem. Biophys. res. Commun. 1986; 139: 858
   Google Scholar
• McMohan G., Hanson L., Lee J. J., Wogan G., Mohan G., Davis E., Wogan G. N. Identification of an Activated C-Ki-ras Oncogenes in Rat Liver Tumors Induced by Aflatoxin B1. Proc. Natl. Acad. Sci. 1986; 83: 9418
   PubMed Web of Science ®Google Scholar
• McMohan G., Davis E., Wogan G. N. Characterization of C-Ki-ras Oncogene Alleles by Direct Sequencing of Enzymatically Amplified DNA from Carcinogen-Induced Tumors. Proc. Natl. Acad. Sci. 1987; 84: 4974
   PubMed Web of Science ®Google Scholar
• Mc Mohan G., Davis F. F., Huber I. J., Kim Y., Wogan G. N. Characterization of C-Ki-ras and N-ras Oncogenes in Aflatoxin B1-Induced Rat Liver Tumors. Proc. Natl. Acad. Sci. 1990; 87: 1104
   PubMed Web of Science ®Google Scholar
• Marian Koenraad, Mathews Kate, Holde Kansal, Van Bailey. Replcation Blocks and Sequence Interaction Specifities in the Codon 12 Region of the C-Ha-ras Proto-oncogene-Induced by Four Carcinogens In Vitro. J. Biol. Chem. 1989; 264: 13226
   PubMedGoogle Scholar
• Sinha S., Webber C., Marshall C. J., Knowles M. A., Proctor A., Barren N. C., Neal G. E. Activation of ras Oncogene in Aflatoxin B1-Induced Rat Liver Carcinogenesis. Proc. Natl. Acad. Sci. 1988; 85: 3673
   PubMed Web of Science ®Google Scholar
• Bauer-Hofmann R., Bushmann A., Wright A. S., Schwarz M. Mutations in the Haras Proto-oncogene in Spontaneous and Chemically Induced Liver Tumors of the CFI Mouse. Carcinogenesis 1990; 11: 1875
   PubMed Web of Science ®Google Scholar
• Chang Y. J., Mathews C., Mangold K., Marian K., Hendricks J., Bailey G. Analysis of ras Gene Mutations in Rainbow Trout, Liver Tumors Initiated by Aflatoxin B1. Mol. Carcinog. 1991; 4: 112
   PubMed Web of Science ®Google Scholar